Cellebrite DI (CLBT) Share-based Compensation (2021 - 2025)

Cellebrite DI (CLBT) has reported Share-based Compensation for 5 consecutive years, with $12.0 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Share-based Compensation rose 29.43% year-over-year to $12.0 million; the TTM figure through Dec 2025 stood at $44.9 million (up 46.83% YoY), while the FY2025 annual figure was $44.9 million, up 46.83% from the prior year.
• Share-based Compensation came in at $12.0 million for Q4 2025 at Cellebrite DI, down from $15.3 million in the prior quarter.
• The five-year high for Share-based Compensation was $15.3 million in Q3 2025, with the low at $1.4 million in Q3 2021.
• Average Share-based Compensation over 5 years is $6.1 million, with a median of $5.0 million recorded in 2023.
• Across the five-year window, Share-based Compensation surged 144.04% in 2022 and advanced 27.6% in 2023, its largest moves.
• Year by year, Share-based Compensation stood at $1.7 million in 2021, then jumped by 128.0% to $3.8 million in 2022, then jumped by 33.61% to $5.1 million in 2023, then soared by 83.18% to $9.3 million in 2024, then rose by 29.43% to $12.0 million in 2025.
• According to Business Quant data, Share-based Compensation over the past three periods registered $12.0 million, $15.3 million, and $8.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.